Literature DB >> 17074591

Translocation (14;18)(q32;q21) in acute lymphoblastic leukemia: a study of 12 cases and review of the literature.

Pina D'Achille1, John F Seymour, Lynda J Campbell.   

Abstract

We present a series of 12 cases of de novo acute lymphoblastic leukemia (ALL) with translocation t(14;18)(q32;q21). The median age of patients at presentation was 65.5 years, and no patient presented with a past history or any clinical evidence of lymphoma. A Burkitt translocation was identified in 4 of the 12 cases by conventional cytogenetics but fluorescence in situ hybridization using a MYC probe identified a further three cases of MYC rearrangement: one with a cryptic t(8;14) involving the der(14)t(14;18), one showing MYC translocated onto a marker chromosome, and one associated with a t(8;9)(q24;p13) translocation. A review of the literature identified an extremely close association between the t(14;18) and the t(8;9), with the latter translocation found only in the presence of t(14;18). The present study confirms the previously reported dismal prognosis of t(14;18)-associated ALL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074591     DOI: 10.1016/j.cancergencyto.2006.07.005

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors:  Matija Snuderl; Olga K Kolman; Yi-Bin Chen; Jessie J Hsu; Adam M Ackerman; Paola Dal Cin; Judith A Ferry; Nancy Lee Harris; Robert P Hasserjian; Lawrence R Zukerberg; Jeremy S Abramson; Ephraim P Hochberg; Hang Lee; Alfred I Lee; Christiana E Toomey; Aliyah R Sohani
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

2.  Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges.

Authors:  Laura Moench; Zohar Sachs; Garth Aasen; Michelle Dolan; Vanessa Dayton; Elizabeth L Courville
Journal:  Leuk Lymphoma       Date:  2016-02-18

Review 3.  Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia.

Authors:  Deborah A Thomas; Susan O'Brien; Hagop M Kantarjian
Journal:  Hematol Oncol Clin North Am       Date:  2009-10       Impact factor: 3.722

4.  Translocation and deletion breakpoints in cancer genomes are associated with potential non-B DNA-forming sequences.

Authors:  Albino Bacolla; John A Tainer; Karen M Vasquez; David N Cooper
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

5.  De Novo Precursor B-Lymphoblastic Leukemia/Lymphoma With Double-Hit Gene Rearrangements (MYC/BCL-2) Presented With Spinal Cord Compression and Acquired Factor XIII Deficiency.

Authors:  Dina Sameh Soliman; Ahmad Al-Sabbagh; Feryal Ibrahim; Shehab Fareed; Mohamed Talaat; Mohamed A Yassin
Journal:  J Hematol (Brossard)       Date:  2017-07-20

6.  De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a case report and literature review.

Authors:  Akiko Uchida; Yasushi Isobe; Yu Uemura; Yuji Nishio; Hirotaka Sakai; Masayuki Kato; Kaori Otsubo; Masahiro Hoshikawa; Masayuki Takagi; Ikuo Miura
Journal:  BMC Clin Pathol       Date:  2017-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.